Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies

MLA

Karasavvidou EM, et al. “Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies.” Drug Design, Development and Therapy, vol. ume 16, Aug. 2022, pp. 2659–80. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.bdec0278a34e43318974d470372268a8&authtype=sso&custid=ns315887.

APA

Karasavvidou EM, Tranos P, & Panos GD. (2022). Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies. Drug Design, Development and Therapy, ume 16, 2659–2680.

Chicago

Karasavvidou EM, Tranos P, and Panos GD. 2022. “Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies.” Drug Design, Development and Therapy ume 16 (August): 2659–80. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.bdec0278a34e43318974d470372268a8&authtype=sso&custid=ns315887.